Systematic Immunotherapy Target Discovery Using Genome-Scale In Vivo CRISPR Screens in CD8 T CellsMatthew B. Dong, Sidi Chen, Johanna Shen et al.|Cell|2019Cited by 326
In vivo CRISPR screening in CD8 T cells with AAV–Sleeping Beauty hybrid vectors identifies membrane targets for improving immunotherapy for glioblastomaLupeng Ye, Sidi Chen, Youssef Errami et al.|Nature Biotechnology|2019Cited by 205
A genome-scale gain-of-function CRISPR screen in CD8 T cells identifies proline metabolism as a means to enhance CAR-T therapyLupeng Ye, Sidi Chen, Paul Clark et al.|Cell Metabolism|2022Cited by 190
One-step generation of modular CAR-T cells with AAV–Cpf1Xiaoyun Dai, Sidi Chen, Youssef Errami et al.|Nature Methods|2019Cited by 168
CRISPR-GEMM Pooled Mutagenic Screening Identifies KMT2D as a Major Modulator of Immune Checkpoint BlockadeGuangchuan Wang, Sidi Chen, Yujing Cheng et al.|Cancer Discovery|2020Cited by 143